Rose Wafula1, Sarah Masyuko, Lucy Ng'ang'a, Andrea A Kim, Anthony Gichangi, Irene Mukui, James Batuka, Evelyn W Ngugi, William K Maina, Sandra Schwarcz. 1. *National AIDS and Sexually Transmitted Infection (STI) Control Programme, Ministry of Health, Nairobi, Kenya; †Division of Global HIV/AIDS, Center for Global Health, US Centers for Disease Control and Prevention, Nairobi, Kenya; ‡United States Agency for International Development, Nairobi, Kenya; and §Global Health Sciences, University of California, San Francisco, CA.
Abstract
BACKGROUND: Increasing access to care and treatment for HIV-infected persons is a goal in Kenya's response to the HIV epidemic. Using data from the second Kenya AIDS Indicator Survey (KAIS 2012), we describe coverage of services received among adults and adolescents who were enrolled in HIV care. METHODS: KAIS 2012 was a population-based survey that collected information from persons aged 15-64 years that included self-reported HIV status, and for persons reporting HIV infection, use of HIV care and antiretroviral therapy (ART). Blood specimens were collected and tested for HIV. HIV-positive specimens were tested for CD4 counts and viral load. RESULTS: Among 363 persons who reported HIV infection, 93.4% [95% confidence interval (CI): 87.2 to 99.6] had ever received HIV care. Among those receiving HIV care, 96.3% (95% CI: 94.1 to 98.4) were using cotrimoxazole prophylaxis, and 74.6% (95% CI: 69.0 to 80.2) were receiving ART. A lower proportion of persons in care and not on ART reported using cotrimoxazole (89.5%, 95% CI: 82.5 to 96.5 compared with 98.6%, 95% CI: 97.1 to 100) and had a CD4 count measurement done (72.9%, 95% CI: 64.0 to 81.9 compared with 90.0%, 95% CI: 82.8 to 97.3) than persons in care and on ART, respectively. Among persons in care and not on ART, 23.2% (95% CI: 6.8 to 39.7) had CD4 counts ≤350 cells per microliter. Viral suppression was observed in 75.3% (95% CI: 68.7 to 81.9) of persons on ART. CONCLUSIONS: Linkage and retention in care are high among persons with known HIV infection. However, improvements in care for the pre-ART population are needed. Viral suppression rates were comparable to developed settings.
BACKGROUND: Increasing access to care and treatment for HIV-infectedpersons is a goal in Kenya's response to the HIV epidemic. Using data from the second Kenya AIDS Indicator Survey (KAIS 2012), we describe coverage of services received among adults and adolescents who were enrolled in HIV care. METHODS: KAIS 2012 was a population-based survey that collected information from persons aged 15-64 years that included self-reported HIV status, and for persons reporting HIV infection, use of HIV care and antiretroviral therapy (ART). Blood specimens were collected and tested for HIV. HIV-positive specimens were tested for CD4 counts and viral load. RESULTS: Among 363 persons who reported HIV infection, 93.4% [95% confidence interval (CI): 87.2 to 99.6] had ever received HIV care. Among those receiving HIV care, 96.3% (95% CI: 94.1 to 98.4) were using cotrimoxazole prophylaxis, and 74.6% (95% CI: 69.0 to 80.2) were receiving ART. A lower proportion of persons in care and not on ART reported using cotrimoxazole (89.5%, 95% CI: 82.5 to 96.5 compared with 98.6%, 95% CI: 97.1 to 100) and had a CD4 count measurement done (72.9%, 95% CI: 64.0 to 81.9 compared with 90.0%, 95% CI: 82.8 to 97.3) than persons in care and on ART, respectively. Among persons in care and not on ART, 23.2% (95% CI: 6.8 to 39.7) had CD4 counts ≤350 cells per microliter. Viral suppression was observed in 75.3% (95% CI: 68.7 to 81.9) of persons on ART. CONCLUSIONS: Linkage and retention in care are high among persons with known HIV infection. However, improvements in care for the pre-ART population are needed. Viral suppression rates were comparable to developed settings.
Authors: T R O'Brien; W A Blattner; D Waters; E Eyster; M W Hilgartner; A R Cohen; N Luban; A Hatzakis; L M Aledort; P S Rosenberg; W J Miley; B L Kroner; J J Goedert Journal: JAMA Date: 1996-07-10 Impact factor: 56.272
Authors: Alex Hamilton; Jesus M Garcia-Calleja; Marco Vitoria; Charles Gilks; Yves Souteyrand; Kevin De Cock; Siobhan Crowley Journal: Sex Transm Infect Date: 2010-10 Impact factor: 3.519
Authors: Davies O Kimanga; Samuel Ogola; Mamo Umuro; Anne Ng'ang'a; Lucy Kimondo; Patrick Murithi; James Muttunga; Wanjiru Waruiru; Ibrahim Mohammed; Shahnaaz Sharrif; Kevin M De Cock; Andrea A Kim Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731
Authors: F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg Journal: N Engl J Med Date: 1998-03-26 Impact factor: 91.245
Authors: Suzanne M Ingle; Margaret May; Kerry Uebel; Venessa Timmerman; Eduan Kotze; Max Bachmann; Jonathan A C Sterne; Matthias Egger; Lara Fairall Journal: AIDS Date: 2010-11-13 Impact factor: 4.177
Authors: Jason F Okulicz; Vincent C Marconi; Michael L Landrum; Scott Wegner; Amy Weintrob; Anuradha Ganesan; Braden Hale; Nancy Crum-Cianflone; Judith Delmar; Vincent Barthel; Gerald Quinnan; Brian K Agan; Matthew J Dolan Journal: J Infect Dis Date: 2009-12-01 Impact factor: 5.226
Authors: William K Maina; Andrea A Kim; George W Rutherford; Malayah Harper; Boniface O K'Oyugi; Shahnaaz Sharif; George Kichamu; Nicholas M Muraguri; Willis Akhwale; Kevin M De Cock Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731
Authors: Jacob O Odhiambo; Timothy A Kellogg; Andrea A Kim; Lucy Ng'ang'a; Irene Mukui; Mamo Umuro; Ibrahim Mohammed; Kevin M De Cock; Davies O Kimanga; Sandra Schwarcz Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731
Authors: Wanjiru Waruiru; Andrea A Kim; Davies O Kimanga; James Ng'ang'a; Sandra Schwarcz; Lucy Kimondo; Anne Ng'ang'a; Mamo Umuro; Mary Mwangi; James K Ojwang'; William K Maina Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731
Authors: Sue Napierala; Sungai T Chabata; Calum Davey; Elizabeth Fearon; Joanna Busza; Phillis Mushati; Owen Mugurungi; Karin Hatzold; Valentina Cambiano; Andrew Phillips; James R Hargreaves; Frances M Cowan Journal: PLoS One Date: 2022-06-28 Impact factor: 3.752
Authors: William K Maina; Andrea A Kim; George W Rutherford; Malayah Harper; Boniface O K'Oyugi; Shahnaaz Sharif; George Kichamu; Nicholas M Muraguri; Willis Akhwale; Kevin M De Cock Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731
Authors: Jacob O Odhiambo; Timothy A Kellogg; Andrea A Kim; Lucy Ng'ang'a; Irene Mukui; Mamo Umuro; Ibrahim Mohammed; Kevin M De Cock; Davies O Kimanga; Sandra Schwarcz Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731
Authors: Becky L Genberg; Hana Lee; Joseph W Hogan; Fatma Some; Juddy Wachira; Xiaotian K Wu; Paula Braitstein Journal: J Acquir Immune Defic Syndr Date: 2018-08-01 Impact factor: 3.731
Authors: Sarah J Masyuko; Peter K Cherutich; Marielle G Contesse; Peter M Maingi; Beatrice M Wamuti; Paul M Macharia; David E Bukusi; Felix A Otieno; Hans Ml Spiegel; Matthew D Dunbar; Matthew R Golden; Barbra A Richardson; Carey Farquhar Journal: J Int AIDS Soc Date: 2019-07 Impact factor: 5.396
Authors: Elizabeth Fearon; Siyanda Tenza; Cecilia Mokoena; Kerushini Moodley; Adrian D Smith; Adam Bourne; Peter Weatherburn; Thesla Palanee-Phillips Journal: PLoS One Date: 2020-06-17 Impact factor: 3.240
Authors: Maria F Nardell; Oluwatomi Adeoti; Carson Peters; Bernard Kakuhikire; Caroline Govathson-Mandimika; Lawrence Long; Sophie Pascoe; Alexander C Tsai; Ingrid T Katz Journal: J Int AIDS Soc Date: 2022-03 Impact factor: 5.396